Blog
Tag: Press Releases
Filter by Category:
Filter by Tag:
Funding for “Validating Remote Developmental Assessments in SYNGAP1-Related Disorders” grant awarded to co-PIs Julie Orlando DPT, PhD of Center for Epilepsy and Neurodevelopmental Disorders at U Penn and Dr. Jill McKee of Children’s Hospital of Philadelphia (CHOP) from CURE SYNGAP1 – PR49
Global SYNGAP1 Organizations Form CURE SYNGAP1 COLLECTIVE (CSC) to Accelerate Treatments and Ensure Patient Access through Coordinated Global Action – PR48
CURE SYNGAP1, fka SynGAP Research Fund (SRF), Announces the Release of Their 2025 Impact Report – Unlock Their Tomorrow – PR47
CURE SYNGAP1 Announces $111,960 Investment in RARE-X Partnership to Advance ProMMIS Patient-Reported Outcome Measure Data Collection – PR46
SynGAP Research Fund (SRF) Announces Formal Transition to CURE SYNGAP1, Reinforcing Commitment to Treatment Development – PR44
CURE SYNGAP1 (fka SynGAP Research Fund) Awards Grant to Dr. Ryan Dhindsa as Part of Biomarker Project to Transform SYNGAP1 Research – PR43
Dr. Paul Donlin-Asp of the University of Edinburgh to dissect the molecular functions and regulation of local SYNGAP1 protein synthesis with support from CURE SYNGAP1 (fka SynGAP Research Fund) – PR42
Dr. Àlex Bayés Puig Advances SYNGAP1 Research with New SynGAP Biomarker Study Funded by CURE SYNGAP1 – PR41
Prof. Kristian Strømgaard is Awarded CURE SYNGAP1 Grant for Research on Biomolecular Condensates – PR40
Progress in SYNGAP1 Therapeutic Development and the Early History of the SynGAP Research Fund (SRF) Chronicled in SRF’s First Published Paper – PR39
SynGAP Research Fund (SRF), dba Cure SYNGAP1, Announces Board of Trustees Update – PR38
Dr. Vikaas Sohal of The University of California, San Francisco Receives a $130,000 SynGAP Research Fund (SRF) Grant to Explore Therapeutic Strategies for Reversing Cognitive Deficits in SYNGAP1-Related Disorders – PR37
Dr. Julia Dallman Awarded SynGAP Research Fund (SRF) Grant for SYNGAP1 Research Targeting Gastro-Intestinal Treatment Development – PR36
Dr. Megan Abbott and the University of Colorado Awarded $450,000 Establishing a Clinical Research Center of Excellence that will also Serve as a Second Site for SYNGAP1 ProMMiS – PR35
SynGAP Research Fund (SRF) dba Cure SYNGAP1 Announces the Release of Their SYNGAP1 Impact Report for 2024 – PR34
4M Therapeutics Awarded $120,000 Grant from SynGAP Research Fund to Evaluate GSK3β Inhibition in Preclinical SYNGAP1-Related Disorders Research
Michael Courtney of Turku Bioscience Center Receives Grant for Research on SYNGAP1 Missense Variants and Drug Repurposing from SynGAP Research Fund (SRF) dba Cure SYNGAP1 – PR33
$230K Grant Awarded to The Jackson Laboratory (JAX) to Advance Translational Research on SYNGAP1-Related Disorders – PR32
